nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—CYP2C8—Mometasone—atopic dermatitis	0.0536	0.0926	CbGbCtD
Regorafenib—CYP2B6—Diphenhydramine—atopic dermatitis	0.0406	0.0702	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—atopic dermatitis	0.0321	0.0555	CbGbCtD
Regorafenib—CYP2C8—Loratadine—atopic dermatitis	0.0308	0.0532	CbGbCtD
Regorafenib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0287	0.0496	CbGbCtD
Regorafenib—ABCB1—Tacrolimus—atopic dermatitis	0.0285	0.0492	CbGbCtD
Regorafenib—CYP2C19—Diphenhydramine—atopic dermatitis	0.0258	0.0446	CbGbCtD
Regorafenib—CYP2C19—Loratadine—atopic dermatitis	0.0258	0.0446	CbGbCtD
Regorafenib—CYP2C9—Loratadine—atopic dermatitis	0.0215	0.0371	CbGbCtD
Regorafenib—CYP2C9—Diphenhydramine—atopic dermatitis	0.0215	0.0371	CbGbCtD
Regorafenib—ABCB1—Loratadine—atopic dermatitis	0.0208	0.036	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—atopic dermatitis	0.02	0.0345	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—atopic dermatitis	0.0191	0.0329	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—atopic dermatitis	0.0171	0.0296	CbGbCtD
Regorafenib—CYP3A4—Tacrolimus—atopic dermatitis	0.0171	0.0295	CbGbCtD
Regorafenib—CYP2C19—Prednisone—atopic dermatitis	0.0143	0.0247	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—atopic dermatitis	0.0141	0.0243	CbGbCtD
Regorafenib—CYP3A4—Loratadine—atopic dermatitis	0.0125	0.0216	CbGbCtD
Regorafenib—ABCB1—Betamethasone—atopic dermatitis	0.0124	0.0214	CbGbCtD
Regorafenib—ABCB1—Prednisolone—atopic dermatitis	0.0122	0.0211	CbGbCtD
Regorafenib—DDR2—skin epidermis—atopic dermatitis	0.012	0.17	CbGeAlD
Regorafenib—ABCB1—Hydrocortisone—atopic dermatitis	0.0116	0.02	CbGbCtD
Regorafenib—ABCB1—Prednisone—atopic dermatitis	0.0115	0.0199	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0114	0.0197	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—atopic dermatitis	0.0106	0.0184	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—atopic dermatitis	0.00893	0.0154	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—atopic dermatitis	0.00865	0.015	CbGbCtD
Regorafenib—CYP2C9—Dexamethasone—atopic dermatitis	0.00743	0.0128	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—atopic dermatitis	0.00742	0.0128	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—atopic dermatitis	0.00733	0.0127	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—atopic dermatitis	0.00721	0.0125	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00694	0.012	CbGbCtD
Regorafenib—CYP3A4—Prednisone—atopic dermatitis	0.00692	0.012	CbGbCtD
Regorafenib—FGFR2—skin epidermis—atopic dermatitis	0.00613	0.0869	CbGeAlD
Regorafenib—CYP3A4—Dexamethasone—atopic dermatitis	0.00432	0.00746	CbGbCtD
Regorafenib—KIT—skin epidermis—atopic dermatitis	0.00426	0.0603	CbGeAlD
Regorafenib—DDR2—skin of body—atopic dermatitis	0.00372	0.0527	CbGeAlD
Regorafenib—RET—neck—atopic dermatitis	0.00309	0.0438	CbGeAlD
Regorafenib—FGFR2—neck—atopic dermatitis	0.00293	0.0416	CbGeAlD
Regorafenib—FLT1—neck—atopic dermatitis	0.00272	0.0386	CbGeAlD
Regorafenib—RAF1—neck—atopic dermatitis	0.0027	0.0383	CbGeAlD
Regorafenib—DDR2—head—atopic dermatitis	0.00242	0.0344	CbGeAlD
Regorafenib—KDR—neck—atopic dermatitis	0.0023	0.0326	CbGeAlD
Regorafenib—MAPK11—head—atopic dermatitis	0.0023	0.0326	CbGeAlD
Regorafenib—KIT—neck—atopic dermatitis	0.00204	0.0289	CbGeAlD
Regorafenib—PDGFRB—neck—atopic dermatitis	0.00199	0.0282	CbGeAlD
Regorafenib—FGFR2—skin of body—atopic dermatitis	0.0019	0.0269	CbGeAlD
Regorafenib—RAF1—skin of body—atopic dermatitis	0.00175	0.0248	CbGeAlD
Regorafenib—FLT4—head—atopic dermatitis	0.00148	0.0209	CbGeAlD
Regorafenib—KIT—skin of body—atopic dermatitis	0.00132	0.0187	CbGeAlD
Regorafenib—RET—head—atopic dermatitis	0.0013	0.0185	CbGeAlD
Regorafenib—PDGFRB—skin of body—atopic dermatitis	0.00129	0.0183	CbGeAlD
Regorafenib—FGFR2—head—atopic dermatitis	0.00124	0.0176	CbGeAlD
Regorafenib—EPHA2—head—atopic dermatitis	0.00122	0.0173	CbGeAlD
Regorafenib—TEK—head—atopic dermatitis	0.00119	0.0168	CbGeAlD
Regorafenib—FLT1—head—atopic dermatitis	0.00115	0.0163	CbGeAlD
Regorafenib—ABL1—skin of body—atopic dermatitis	0.00115	0.0163	CbGeAlD
Regorafenib—RAF1—head—atopic dermatitis	0.00114	0.0162	CbGeAlD
Regorafenib—PDGFRA—head—atopic dermatitis	0.00108	0.0153	CbGeAlD
Regorafenib—KDR—head—atopic dermatitis	0.000971	0.0138	CbGeAlD
Regorafenib—KIT—head—atopic dermatitis	0.00086	0.0122	CbGeAlD
Regorafenib—PDGFRB—head—atopic dermatitis	0.00084	0.0119	CbGeAlD
Regorafenib—ABL1—head—atopic dermatitis	0.000749	0.0106	CbGeAlD
Regorafenib—CYP2B6—skin of body—atopic dermatitis	0.000668	0.00947	CbGeAlD
Regorafenib—Angiopathy—Tacrolimus—atopic dermatitis	0.000437	0.00247	CcSEcCtD
Regorafenib—CYP2B6—head—atopic dermatitis	0.000436	0.00618	CbGeAlD
Regorafenib—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000434	0.00246	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000433	0.00245	CcSEcCtD
Regorafenib—Fatigue—Loratadine—atopic dermatitis	0.000432	0.00244	CcSEcCtD
Regorafenib—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00043	0.00244	CcSEcCtD
Regorafenib—Pain—Loratadine—atopic dermatitis	0.000428	0.00242	CcSEcCtD
Regorafenib—Infection—Mometasone—atopic dermatitis	0.000427	0.00242	CcSEcCtD
Regorafenib—Alopecia—Tacrolimus—atopic dermatitis	0.000426	0.00241	CcSEcCtD
Regorafenib—Malnutrition—Tacrolimus—atopic dermatitis	0.000419	0.00237	CcSEcCtD
Regorafenib—Vomiting—Dimenhydrinate—atopic dermatitis	0.000414	0.00234	CcSEcCtD
Regorafenib—Vomiting—Diphenhydramine—atopic dermatitis	0.000414	0.00234	CcSEcCtD
Regorafenib—Rash—Dimenhydrinate—atopic dermatitis	0.00041	0.00232	CcSEcCtD
Regorafenib—Rash—Diphenhydramine—atopic dermatitis	0.00041	0.00232	CcSEcCtD
Regorafenib—Dermatitis—Diphenhydramine—atopic dermatitis	0.00041	0.00232	CcSEcCtD
Regorafenib—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00041	0.00232	CcSEcCtD
Regorafenib—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00041	0.00232	CcSEcCtD
Regorafenib—Dry skin—Prednisolone—atopic dermatitis	0.000408	0.00231	CcSEcCtD
Regorafenib—Headache—Diphenhydramine—atopic dermatitis	0.000408	0.00231	CcSEcCtD
Regorafenib—Headache—Dimenhydrinate—atopic dermatitis	0.000408	0.00231	CcSEcCtD
Regorafenib—Vomiting—Pimecrolimus—atopic dermatitis	0.0004	0.00226	CcSEcCtD
Regorafenib—Dry skin—Hydrocortisone—atopic dermatitis	0.000398	0.00225	CcSEcCtD
Regorafenib—Rash—Pimecrolimus—atopic dermatitis	0.000397	0.00224	CcSEcCtD
Regorafenib—Dermatitis—Pimecrolimus—atopic dermatitis	0.000396	0.00224	CcSEcCtD
Regorafenib—Abdominal pain—Loratadine—atopic dermatitis	0.000396	0.00224	CcSEcCtD
Regorafenib—Body temperature increased—Loratadine—atopic dermatitis	0.000396	0.00224	CcSEcCtD
Regorafenib—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.000395	0.00224	CcSEcCtD
Regorafenib—Headache—Pimecrolimus—atopic dermatitis	0.000394	0.00223	CcSEcCtD
Regorafenib—Tremor—Tacrolimus—atopic dermatitis	0.000393	0.00222	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000389	0.0022	CcSEcCtD
Regorafenib—Anaemia—Tacrolimus—atopic dermatitis	0.000388	0.00219	CcSEcCtD
Regorafenib—Nausea—Dimenhydrinate—atopic dermatitis	0.000386	0.00219	CcSEcCtD
Regorafenib—Nausea—Diphenhydramine—atopic dermatitis	0.000386	0.00219	CcSEcCtD
Regorafenib—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000385	0.00218	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000383	0.00217	CcSEcCtD
Regorafenib—Leukopenia—Tacrolimus—atopic dermatitis	0.000375	0.00212	CcSEcCtD
Regorafenib—Decreased appetite—Mometasone—atopic dermatitis	0.000374	0.00212	CcSEcCtD
Regorafenib—Nausea—Pimecrolimus—atopic dermatitis	0.000374	0.00211	CcSEcCtD
Regorafenib—Fatigue—Mometasone—atopic dermatitis	0.000371	0.0021	CcSEcCtD
Regorafenib—Pain—Mometasone—atopic dermatitis	0.000368	0.00208	CcSEcCtD
Regorafenib—Hypertension—Tacrolimus—atopic dermatitis	0.000362	0.00205	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.00036	0.00204	CcSEcCtD
Regorafenib—Asthenia—Loratadine—atopic dermatitis	0.000359	0.00203	CcSEcCtD
Regorafenib—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000356	0.00201	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000354	0.00201	CcSEcCtD
Regorafenib—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000352	0.00199	CcSEcCtD
Regorafenib—Dry mouth—Tacrolimus—atopic dermatitis	0.000349	0.00198	CcSEcCtD
Regorafenib—Diarrhoea—Loratadine—atopic dermatitis	0.000343	0.00194	CcSEcCtD
Regorafenib—Dry skin—Dexamethasone—atopic dermatitis	0.00034	0.00193	CcSEcCtD
Regorafenib—Dry skin—Betamethasone—atopic dermatitis	0.00034	0.00193	CcSEcCtD
Regorafenib—Infection—Tacrolimus—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Regorafenib—Abdominal pain—Mometasone—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Regorafenib—Body temperature increased—Mometasone—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Regorafenib—Weight decreased—Hydrocortisone—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000338	0.00191	CcSEcCtD
Regorafenib—Hypokalaemia—Betamethasone—atopic dermatitis	0.000338	0.00191	CcSEcCtD
Regorafenib—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000338	0.00191	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisolone—atopic dermatitis	0.000336	0.0019	CcSEcCtD
Regorafenib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000336	0.0019	CcSEcCtD
Regorafenib—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000335	0.0019	CcSEcCtD
Regorafenib—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000335	0.00189	CcSEcCtD
Regorafenib—Infestation—Hydrocortisone—atopic dermatitis	0.000335	0.00189	CcSEcCtD
Regorafenib—Skin disorder—Tacrolimus—atopic dermatitis	0.000332	0.00188	CcSEcCtD
Regorafenib—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00033	0.00187	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000328	0.00186	CcSEcCtD
Regorafenib—Vomiting—Loratadine—atopic dermatitis	0.000319	0.0018	CcSEcCtD
Regorafenib—Rash—Loratadine—atopic dermatitis	0.000316	0.00179	CcSEcCtD
Regorafenib—Dermatitis—Loratadine—atopic dermatitis	0.000316	0.00179	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000314	0.00178	CcSEcCtD
Regorafenib—Infestation—Methylprednisolone—atopic dermatitis	0.000314	0.00178	CcSEcCtD
Regorafenib—Headache—Loratadine—atopic dermatitis	0.000314	0.00178	CcSEcCtD
Regorafenib—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000311	0.00176	CcSEcCtD
Regorafenib—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.00031	0.00175	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—atopic dermatitis	0.000309	0.00175	CcSEcCtD
Regorafenib—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000309	0.00175	CcSEcCtD
Regorafenib—Asthenia—Mometasone—atopic dermatitis	0.000308	0.00175	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000308	0.00174	CcSEcCtD
Regorafenib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000308	0.00174	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—atopic dermatitis	0.000308	0.00174	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000302	0.00171	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—atopic dermatitis	0.0003	0.0017	CcSEcCtD
Regorafenib—Nausea—Loratadine—atopic dermatitis	0.000298	0.00168	CcSEcCtD
Regorafenib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000297	0.00168	CcSEcCtD
Regorafenib—Dry skin—Prednisone—atopic dermatitis	0.000296	0.00168	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000295	0.00167	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000295	0.00167	CcSEcCtD
Regorafenib—Fatigue—Tacrolimus—atopic dermatitis	0.000295	0.00167	CcSEcCtD
Regorafenib—Diarrhoea—Mometasone—atopic dermatitis	0.000294	0.00167	CcSEcCtD
Regorafenib—Hypokalaemia—Prednisone—atopic dermatitis	0.000294	0.00166	CcSEcCtD
Regorafenib—Pain—Tacrolimus—atopic dermatitis	0.000293	0.00166	CcSEcCtD
Regorafenib—Weight decreased—Betamethasone—atopic dermatitis	0.00029	0.00164	CcSEcCtD
Regorafenib—Weight decreased—Dexamethasone—atopic dermatitis	0.00029	0.00164	CcSEcCtD
Regorafenib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000286	0.00162	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000285	0.00161	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—atopic dermatitis	0.000284	0.00161	CcSEcCtD
Regorafenib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000284	0.00161	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000284	0.00161	CcSEcCtD
Regorafenib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000284	0.00161	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—atopic dermatitis	0.000283	0.0016	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000282	0.0016	CcSEcCtD
Regorafenib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000282	0.0016	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000282	0.0016	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000282	0.0016	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—atopic dermatitis	0.00028	0.00159	CcSEcCtD
Regorafenib—Myocardial infarction—Betamethasone—atopic dermatitis	0.00028	0.00159	CcSEcCtD
Regorafenib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00028	0.00158	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000277	0.00157	CcSEcCtD
Regorafenib—Vomiting—Mometasone—atopic dermatitis	0.000273	0.00155	CcSEcCtD
Regorafenib—Rash—Mometasone—atopic dermatitis	0.000271	0.00153	CcSEcCtD
Regorafenib—Dermatitis—Mometasone—atopic dermatitis	0.000271	0.00153	CcSEcCtD
Regorafenib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000271	0.00153	CcSEcCtD
Regorafenib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000271	0.00153	CcSEcCtD
Regorafenib—Headache—Mometasone—atopic dermatitis	0.000269	0.00152	CcSEcCtD
Regorafenib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000267	0.00151	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000262	0.00148	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000262	0.00148	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—atopic dermatitis	0.000261	0.00148	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—atopic dermatitis	0.000258	0.00146	CcSEcCtD
Regorafenib—Haemoglobin—Dexamethasone—atopic dermatitis	0.000258	0.00146	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—atopic dermatitis	0.000257	0.00145	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000257	0.00145	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000256	0.00145	CcSEcCtD
Regorafenib—Nausea—Mometasone—atopic dermatitis	0.000255	0.00145	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000254	0.00144	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—atopic dermatitis	0.000253	0.00143	CcSEcCtD
Regorafenib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000246	0.00139	CcSEcCtD
Regorafenib—Asthenia—Tacrolimus—atopic dermatitis	0.000246	0.00139	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000245	0.00139	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—atopic dermatitis	0.000244	0.00138	CcSEcCtD
Regorafenib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000234	0.00133	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—atopic dermatitis	0.000233	0.00132	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—atopic dermatitis	0.000233	0.00132	CcSEcCtD
Regorafenib—ABCB1—head—atopic dermatitis	0.000233	0.0033	CbGeAlD
Regorafenib—Hypertension—Prednisolone—atopic dermatitis	0.000231	0.00131	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—atopic dermatitis	0.000227	0.00128	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—atopic dermatitis	0.000227	0.00128	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—atopic dermatitis	0.000226	0.00128	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—atopic dermatitis	0.000225	0.00127	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—atopic dermatitis	0.000224	0.00127	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000221	0.00125	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—atopic dermatitis	0.00022	0.00124	CcSEcCtD
Regorafenib—Vomiting—Tacrolimus—atopic dermatitis	0.000218	0.00123	CcSEcCtD
Regorafenib—Rash—Tacrolimus—atopic dermatitis	0.000216	0.00122	CcSEcCtD
Regorafenib—Dermatitis—Tacrolimus—atopic dermatitis	0.000216	0.00122	CcSEcCtD
Regorafenib—Headache—Tacrolimus—atopic dermatitis	0.000214	0.00121	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—atopic dermatitis	0.000213	0.0012	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—atopic dermatitis	0.000212	0.0012	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—atopic dermatitis	0.000212	0.0012	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000209	0.00118	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000208	0.00118	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000207	0.00117	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—atopic dermatitis	0.000205	0.00116	CcSEcCtD
Regorafenib—Nausea—Tacrolimus—atopic dermatitis	0.000203	0.00115	CcSEcCtD
Regorafenib—Angiopathy—Prednisone—atopic dermatitis	0.000203	0.00115	CcSEcCtD
Regorafenib—Infection—Triamcinolone—atopic dermatitis	0.0002	0.00113	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—atopic dermatitis	0.000199	0.00113	CcSEcCtD
Regorafenib—Alopecia—Prednisone—atopic dermatitis	0.000198	0.00112	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000197	0.00111	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000195	0.0011	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—atopic dermatitis	0.000195	0.0011	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—atopic dermatitis	0.000193	0.00109	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—atopic dermatitis	0.000193	0.00109	CcSEcCtD
Regorafenib—Pain—Prednisolone—atopic dermatitis	0.000187	0.00106	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000186	0.00105	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000184	0.00104	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—atopic dermatitis	0.000184	0.00104	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—atopic dermatitis	0.000183	0.00103	CcSEcCtD
Regorafenib—Infection—Betamethasone—atopic dermatitis	0.000181	0.00103	CcSEcCtD
Regorafenib—Infection—Dexamethasone—atopic dermatitis	0.000181	0.00103	CcSEcCtD
Regorafenib—Anaemia—Prednisone—atopic dermatitis	0.00018	0.00102	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000179	0.00101	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000179	0.00101	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000179	0.00101	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000179	0.00101	CcSEcCtD
Regorafenib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000175	0.000988	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—atopic dermatitis	0.000173	0.000981	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—atopic dermatitis	0.000173	0.000979	CcSEcCtD
Regorafenib—Pain—Triamcinolone—atopic dermatitis	0.000172	0.000973	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000169	0.000955	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000169	0.000955	CcSEcCtD
Regorafenib—Hypertension—Prednisone—atopic dermatitis	0.000168	0.000951	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000165	0.000931	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000164	0.000928	CcSEcCtD
Regorafenib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000159	0.000899	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000159	0.000897	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000159	0.000897	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—atopic dermatitis	0.000159	0.000897	CcSEcCtD
Regorafenib—Infection—Prednisone—atopic dermatitis	0.000158	0.000893	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000157	0.000891	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000157	0.000891	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—atopic dermatitis	0.000157	0.00089	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—atopic dermatitis	0.000157	0.00089	CcSEcCtD
Regorafenib—Pain—Dexamethasone—atopic dermatitis	0.000156	0.000883	CcSEcCtD
Regorafenib—Pain—Betamethasone—atopic dermatitis	0.000156	0.000883	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—atopic dermatitis	0.000156	0.000882	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—atopic dermatitis	0.000154	0.000873	CcSEcCtD
Regorafenib—Asthenia—Hydrocortisone—atopic dermatitis	0.000153	0.000867	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000149	0.000844	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000149	0.000844	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000146	0.000827	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—atopic dermatitis	0.000144	0.000816	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000144	0.000816	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—atopic dermatitis	0.000144	0.000816	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—atopic dermatitis	0.000144	0.000816	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—atopic dermatitis	0.000144	0.000816	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—atopic dermatitis	0.000144	0.000814	CcSEcCtD
Regorafenib—Decreased appetite—Prednisone—atopic dermatitis	0.000138	0.000781	CcSEcCtD
Regorafenib—Rash—Prednisolone—atopic dermatitis	0.000138	0.00078	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—atopic dermatitis	0.000138	0.000779	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000137	0.000777	CcSEcCtD
Regorafenib—Fatigue—Prednisone—atopic dermatitis	0.000137	0.000775	CcSEcCtD
Regorafenib—Headache—Prednisolone—atopic dermatitis	0.000137	0.000775	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—atopic dermatitis	0.000136	0.000768	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—atopic dermatitis	0.000135	0.000762	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000134	0.000761	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—atopic dermatitis	0.000134	0.000757	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—atopic dermatitis	0.000131	0.000741	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—atopic dermatitis	0.000131	0.000741	CcSEcCtD
Regorafenib—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00013	0.000735	CcSEcCtD
Regorafenib—Nausea—Prednisolone—atopic dermatitis	0.00013	0.000735	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—atopic dermatitis	0.000128	0.000723	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—atopic dermatitis	0.000128	0.000722	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—atopic dermatitis	0.000127	0.000718	CcSEcCtD
Regorafenib—Rash—Triamcinolone—atopic dermatitis	0.000127	0.000717	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—atopic dermatitis	0.000127	0.000717	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—atopic dermatitis	0.000126	0.000716	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—atopic dermatitis	0.000126	0.000715	CcSEcCtD
Regorafenib—Headache—Triamcinolone—atopic dermatitis	0.000126	0.000713	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—atopic dermatitis	0.000126	0.000711	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—atopic dermatitis	0.000126	0.000711	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—atopic dermatitis	0.000126	0.000711	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000125	0.000706	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—atopic dermatitis	0.000125	0.000706	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—atopic dermatitis	0.000119	0.000676	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—atopic dermatitis	0.000119	0.000674	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—atopic dermatitis	0.000116	0.000656	CcSEcCtD
Regorafenib—Vomiting—Betamethasone—atopic dermatitis	0.000116	0.000656	CcSEcCtD
Regorafenib—Rash—Dexamethasone—atopic dermatitis	0.000115	0.000651	CcSEcCtD
Regorafenib—Rash—Betamethasone—atopic dermatitis	0.000115	0.000651	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—atopic dermatitis	0.000115	0.00065	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—atopic dermatitis	0.000115	0.00065	CcSEcCtD
Regorafenib—Headache—Betamethasone—atopic dermatitis	0.000114	0.000647	CcSEcCtD
Regorafenib—Headache—Dexamethasone—atopic dermatitis	0.000114	0.000647	CcSEcCtD
Regorafenib—Asthenia—Prednisone—atopic dermatitis	0.000114	0.000645	CcSEcCtD
Regorafenib—Diarrhoea—Prednisone—atopic dermatitis	0.000109	0.000615	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—atopic dermatitis	0.000108	0.000613	CcSEcCtD
Regorafenib—Nausea—Betamethasone—atopic dermatitis	0.000108	0.000613	CcSEcCtD
Regorafenib—Vomiting—Prednisone—atopic dermatitis	0.000101	0.000572	CcSEcCtD
Regorafenib—Rash—Prednisone—atopic dermatitis	0.0001	0.000567	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—atopic dermatitis	0.0001	0.000566	CcSEcCtD
Regorafenib—Headache—Prednisone—atopic dermatitis	9.95e-05	0.000563	CcSEcCtD
Regorafenib—Nausea—Prednisone—atopic dermatitis	9.43e-05	0.000534	CcSEcCtD
Regorafenib—KIT—Disease—CCR5—atopic dermatitis	2.22e-05	0.000127	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL18—atopic dermatitis	2.21e-05	0.000127	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CD4—atopic dermatitis	2.21e-05	0.000127	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL10—atopic dermatitis	2.2e-05	0.000126	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—IL2—atopic dermatitis	2.2e-05	0.000126	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—MAPK8—atopic dermatitis	2.19e-05	0.000126	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD8A—atopic dermatitis	2.18e-05	0.000125	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—atopic dermatitis	2.18e-05	0.000125	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NGF—atopic dermatitis	2.18e-05	0.000125	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADSL—atopic dermatitis	2.16e-05	0.000124	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR3—atopic dermatitis	2.15e-05	0.000124	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TAC1—atopic dermatitis	2.15e-05	0.000124	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NPS—atopic dermatitis	2.15e-05	0.000124	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CD4—atopic dermatitis	2.15e-05	0.000124	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MAPK8—atopic dermatitis	2.14e-05	0.000123	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD4—atopic dermatitis	2.12e-05	0.000122	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCR5—atopic dermatitis	2.12e-05	0.000122	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCR3—atopic dermatitis	2.11e-05	0.000121	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—IL6—atopic dermatitis	2.11e-05	0.000121	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CCR5—atopic dermatitis	2.1e-05	0.000121	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CCR5—atopic dermatitis	2.1e-05	0.000121	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—IL6—atopic dermatitis	2.09e-05	0.00012	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—MAPK8—atopic dermatitis	2.08e-05	0.00012	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—MAPK8—atopic dermatitis	2.08e-05	0.000119	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NFKBIA—atopic dermatitis	2.07e-05	0.000119	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NGF—atopic dermatitis	2.06e-05	0.000118	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—IL6—atopic dermatitis	2.04e-05	0.000117	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL10—atopic dermatitis	2.04e-05	0.000117	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CASP8—atopic dermatitis	2.04e-05	0.000117	CbGpPWpGaD
Regorafenib—KIT—Immune System—NFKBIA—atopic dermatitis	2.04e-05	0.000117	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL18—atopic dermatitis	2.03e-05	0.000116	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GLB1—atopic dermatitis	2.01e-05	0.000116	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—IL2—atopic dermatitis	2.01e-05	0.000116	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL5—atopic dermatitis	2e-05	0.000115	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCR5—atopic dermatitis	2e-05	0.000115	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL10—atopic dermatitis	2e-05	0.000115	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCR5—atopic dermatitis	2e-05	0.000115	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD8A—atopic dermatitis	2e-05	0.000115	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CD4—atopic dermatitis	1.97e-05	0.000113	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GLB1—atopic dermatitis	1.97e-05	0.000113	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NFKBIA—atopic dermatitis	1.93e-05	0.000111	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.93e-05	0.000111	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NFKBIA—atopic dermatitis	1.93e-05	0.000111	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAC1—atopic dermatitis	1.92e-05	0.00011	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NPS—atopic dermatitis	1.92e-05	0.00011	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCL5—atopic dermatitis	1.91e-05	0.00011	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL10—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL10—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCL5—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CCR5—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD4—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADSL—atopic dermatitis	1.88e-05	0.000108	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCR3—atopic dermatitis	1.88e-05	0.000108	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—MAPK8—atopic dermatitis	1.87e-05	0.000107	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CASP8—atopic dermatitis	1.87e-05	0.000107	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—IL6—atopic dermatitis	1.87e-05	0.000107	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—atopic dermatitis	1.86e-05	0.000107	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—IL6—atopic dermatitis	1.85e-05	0.000106	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.84e-05	0.000106	CbGpPWpGaD
Regorafenib—KIT—Immune System—CASP8—atopic dermatitis	1.84e-05	0.000105	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—MAPK8—atopic dermatitis	1.82e-05	0.000105	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CXCL8—atopic dermatitis	1.82e-05	0.000105	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.8e-05	0.000103	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL5—atopic dermatitis	1.78e-05	0.000103	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NGF—atopic dermatitis	1.77e-05	0.000102	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.76e-05	0.000101	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—IL6—atopic dermatitis	1.76e-05	0.000101	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL5—atopic dermatitis	1.75e-05	0.000101	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NGF—atopic dermatitis	1.75e-05	0.000101	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CASP8—atopic dermatitis	1.74e-05	0.0001	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL2—atopic dermatitis	1.74e-05	9.99e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CASP8—atopic dermatitis	1.74e-05	9.99e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKBIA—atopic dermatitis	1.74e-05	9.97e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IFNG—atopic dermatitis	1.73e-05	9.95e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL5—atopic dermatitis	1.72e-05	9.9e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCR5—atopic dermatitis	1.72e-05	9.89e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL10—atopic dermatitis	1.71e-05	9.81e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCR5—atopic dermatitis	1.71e-05	9.8e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKBIA—atopic dermatitis	1.7e-05	9.75e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKBIA—atopic dermatitis	1.69e-05	9.72e-05	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—IL6—atopic dermatitis	1.69e-05	9.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CCR5—atopic dermatitis	1.68e-05	9.68e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD4—atopic dermatitis	1.67e-05	9.61e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—MAPK8—atopic dermatitis	1.67e-05	9.58e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.64e-05	9.45e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL5—atopic dermatitis	1.64e-05	9.4e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—atopic dermatitis	1.63e-05	9.38e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL5—atopic dermatitis	1.63e-05	9.37e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NGF—atopic dermatitis	1.62e-05	9.34e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MAPK8—atopic dermatitis	1.6e-05	9.19e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NGF—atopic dermatitis	1.6e-05	9.17e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IFNG—atopic dermatitis	1.59e-05	9.13e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCR5—atopic dermatitis	1.58e-05	9.08e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CASP8—atopic dermatitis	1.57e-05	9e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IFNG—atopic dermatitis	1.56e-05	8.97e-05	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—IL6—atopic dermatitis	1.55e-05	8.92e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCR5—atopic dermatitis	1.55e-05	8.92e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKBIA—atopic dermatitis	1.55e-05	8.89e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL1B—atopic dermatitis	1.54e-05	8.87e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL2—atopic dermatitis	1.54e-05	8.84e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD4—atopic dermatitis	1.54e-05	8.82e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—CD4—atopic dermatitis	1.53e-05	8.79e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CASP8—atopic dermatitis	1.53e-05	8.77e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL10—atopic dermatitis	1.52e-05	8.74e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NGF—atopic dermatitis	1.51e-05	8.7e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NGF—atopic dermatitis	1.51e-05	8.68e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD4—atopic dermatitis	1.51e-05	8.66e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.51e-05	8.65e-05	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—IL6—atopic dermatitis	1.5e-05	8.64e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—atopic dermatitis	1.49e-05	8.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IFNG—atopic dermatitis	1.48e-05	8.51e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IFNG—atopic dermatitis	1.48e-05	8.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCR5—atopic dermatitis	1.47e-05	8.47e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCR5—atopic dermatitis	1.47e-05	8.44e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	1.47e-05	8.44e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.47e-05	8.43e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKBIA—atopic dermatitis	1.46e-05	8.39e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKBIA—atopic dermatitis	1.45e-05	8.31e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—atopic dermatitis	1.43e-05	8.22e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—atopic dermatitis	1.43e-05	8.2e-05	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—IL6—atopic dermatitis	1.43e-05	8.19e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL1B—atopic dermatitis	1.42e-05	8.15e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—atopic dermatitis	1.42e-05	8.14e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—MAPK8—atopic dermatitis	1.42e-05	8.14e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL2—atopic dermatitis	1.41e-05	8.12e-05	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—IL6—atopic dermatitis	1.4e-05	8.04e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CASP8—atopic dermatitis	1.4e-05	8.02e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL1B—atopic dermatitis	1.39e-05	8e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—atopic dermatitis	1.39e-05	8e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PPARA—atopic dermatitis	1.39e-05	7.99e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PPARA—atopic dermatitis	1.39e-05	7.99e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL2—atopic dermatitis	1.39e-05	7.97e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL6—atopic dermatitis	1.37e-05	7.87e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.36e-05	7.83e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	1.36e-05	7.82e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKBIA—atopic dermatitis	1.34e-05	7.7e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.34e-05	7.69e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—atopic dermatitis	1.33e-05	7.65e-05	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—IL6—atopic dermatitis	1.33e-05	7.63e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—IL6—atopic dermatitis	1.33e-05	7.61e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	1.32e-05	7.61e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1B—atopic dermatitis	1.32e-05	7.59e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—atopic dermatitis	1.32e-05	7.59e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1B—atopic dermatitis	1.32e-05	7.57e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—atopic dermatitis	1.32e-05	7.57e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—IL6—atopic dermatitis	1.32e-05	7.57e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—atopic dermatitis	1.32e-05	7.56e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKBIA—atopic dermatitis	1.32e-05	7.56e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—atopic dermatitis	1.31e-05	7.55e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL5—atopic dermatitis	1.31e-05	7.53e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—MAPK8—atopic dermatitis	1.3e-05	7.47e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—atopic dermatitis	1.3e-05	7.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—atopic dermatitis	1.29e-05	7.39e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.28e-05	7.36e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—MAPK8—atopic dermatitis	1.28e-05	7.34e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—atopic dermatitis	1.25e-05	7.2e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.25e-05	7.18e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKBIA—atopic dermatitis	1.25e-05	7.16e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—atopic dermatitis	1.22e-05	7.03e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NGF—atopic dermatitis	1.21e-05	6.97e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—MAPK8—atopic dermatitis	1.21e-05	6.96e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.21e-05	6.96e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CXCL8—atopic dermatitis	1.21e-05	6.95e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—MAPK8—atopic dermatitis	1.21e-05	6.95e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—atopic dermatitis	1.21e-05	6.94e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—atopic dermatitis	1.2e-05	6.92e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	1.19e-05	6.86e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—atopic dermatitis	1.19e-05	6.82e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—atopic dermatitis	1.19e-05	6.82e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—atopic dermatitis	1.19e-05	6.82e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—atopic dermatitis	1.18e-05	6.8e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PPARA—atopic dermatitis	1.18e-05	6.78e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR5—atopic dermatitis	1.18e-05	6.78e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—atopic dermatitis	1.16e-05	6.69e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.16e-05	6.67e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—atopic dermatitis	1.16e-05	6.65e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—atopic dermatitis	1.16e-05	6.65e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—atopic dermatitis	1.15e-05	6.63e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—atopic dermatitis	1.15e-05	6.62e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—atopic dermatitis	1.15e-05	6.59e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.13e-05	6.47e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	1.12e-05	6.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—MAPK8—atopic dermatitis	1.09e-05	6.26e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MAPK8—atopic dermatitis	1.06e-05	6.12e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—atopic dermatitis	1.06e-05	6.11e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—MAPK8—atopic dermatitis	1.06e-05	6.1e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—atopic dermatitis	1.06e-05	6.08e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—atopic dermatitis	1.06e-05	6.08e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—atopic dermatitis	1.05e-05	6.06e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—atopic dermatitis	1.04e-05	5.98e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—atopic dermatitis	1.03e-05	5.92e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—atopic dermatitis	1.02e-05	5.87e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKBIA—atopic dermatitis	1e-05	5.75e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—atopic dermatitis	9.95e-06	5.72e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—atopic dermatitis	9.85e-06	5.66e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MAPK8—atopic dermatitis	9.71e-06	5.58e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—atopic dermatitis	9.56e-06	5.49e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—atopic dermatitis	9.38e-06	5.39e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAPK8—atopic dermatitis	9.16e-06	5.26e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—atopic dermatitis	9.13e-06	5.25e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAPK8—atopic dermatitis	9.07e-06	5.21e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—atopic dermatitis	9.04e-06	5.2e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—atopic dermatitis	8.97e-06	5.15e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—atopic dermatitis	8.91e-06	5.12e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—atopic dermatitis	8.88e-06	5.1e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARA—atopic dermatitis	8.65e-06	4.97e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—atopic dermatitis	8.51e-06	4.89e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—atopic dermatitis	8.49e-06	4.88e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAPK8—atopic dermatitis	8.41e-06	4.83e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—atopic dermatitis	8.3e-06	4.77e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—atopic dermatitis	8.27e-06	4.75e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAPK8—atopic dermatitis	8.26e-06	4.74e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—atopic dermatitis	8.15e-06	4.69e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	8e-06	4.6e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAPK8—atopic dermatitis	7.83e-06	4.5e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAPK8—atopic dermatitis	7.81e-06	4.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—atopic dermatitis	7.74e-06	4.45e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—atopic dermatitis	7.72e-06	4.44e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—atopic dermatitis	7.67e-06	4.4e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	7.65e-06	4.4e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—atopic dermatitis	7.53e-06	4.33e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARA—atopic dermatitis	7.32e-06	4.21e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—atopic dermatitis	7.19e-06	4.13e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—atopic dermatitis	7.14e-06	4.11e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—atopic dermatitis	7.13e-06	4.1e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—atopic dermatitis	7.13e-06	4.09e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	7.04e-06	4.05e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—atopic dermatitis	6.95e-06	4e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—atopic dermatitis	6.82e-06	3.92e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—atopic dermatitis	6.8e-06	3.91e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—atopic dermatitis	6.78e-06	3.9e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—atopic dermatitis	6.78e-06	3.89e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARA—atopic dermatitis	6.54e-06	3.76e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—atopic dermatitis	6.42e-06	3.69e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARA—atopic dermatitis	6.38e-06	3.67e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAPK8—atopic dermatitis	6.27e-06	3.61e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—atopic dermatitis	6.2e-06	3.56e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARA—atopic dermatitis	5.96e-06	3.42e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—atopic dermatitis	5.85e-06	3.36e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—atopic dermatitis	5.79e-06	3.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—atopic dermatitis	5.72e-06	3.29e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—atopic dermatitis	5.37e-06	3.08e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—atopic dermatitis	5.27e-06	3.03e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—atopic dermatitis	5e-06	2.87e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—atopic dermatitis	4.99e-06	2.87e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	4.5e-06	2.58e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—atopic dermatitis	4.01e-06	2.3e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.93e-06	2.26e-05	CbGpPWpGaD
